Company Overview and News
For some time now I have been bullish of Noble Corp (NE), Diamond Offshore (DO), and Transocean (RIG). I have encouraged readers to buy their distressed debt as well as the washed out stocks of these companies. I admit I have been early in my calls on offshore drillers. But in time, I believe I will be proven correct on all of them. With the recent price action we are seeing in both oil prices, as well as in the language from the management of offshore drillers, it's hard to deny things are turning around.
Last week, Noble Corporation (NE) released its monthly fleet status report. A fleet status report includes contract information, drilling status, and planned out-of-service time for every rig. In this part, we’ll look at the report in more detail.
LONDON and CALGARY, Alberta, May 18, 2018 (GLOBE NEWSWIRE) -- Mkango Resources Ltd. (AIM:MKA) (TSX-V:MKA) (the "Company" or "Mkango") is pleased to announce that Mkango and Talaxis Ltd (“Talaxis”), a subsidiary of Noble Group Ltd, have signed the definitive agreements (the “Agreements”) in relation to the transaction announced on November 16, 2017, whereby Talaxis will acquire up to a 75% interest in Lancaster Exploration Ltd (“Lancaster”), the holder of the licence for the Songwe Hill Rare Earths Project (“Songwe”) in Malawi, and up to 49% of Maginito Ltd (“Maginito”):
HOUSTON (Reuters) - Finding roughnecks remains a challenge for oil drillers as rising crude prices increase demand for their services, oilfield executives said on Thursday at a conference in Houston.
In week 19, the week ended May 11, Rowan Companies and Noble Corporation were the best performers among the offshore drilling stocks. Both stocks rose more than 12.0% last week. Seadrill Partners, which rose less than 1.0%, was the lowest performer among its peers.
SINGAPORE: Just seven years ago, Noble Group was an US$11bil-plus Asian commodity powerhouse, trading everything from soybeans to oil. Now it’s worth barely US$80mil, rooted among Singapore’s penny stocks.
This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the ...
Noble Group apparently has some extra time on its hands – it is now targetting critics of the company claiming “trademark infringement”. Of course, most people will realize this argument is ridiculous but we will let you read it in its full. See below for a takedown notice sent by Noble to WordPress over a blog hosted by a shortseller. WordPress made the right decision and did not remove the content.
SINGAPORE: Embattled commodities trader Noble Group Ltd reported a smaller quarterly net loss as it enters a make-or-break phase ahead of shareholder meetings and legal rulings that will decide the company's fate.
Nymex crude oil futures have been above their technical ‘reversion to the mean’ since 2018 began.
Noble Corp. on Wednesday reported a first-quarter loss of $142 million, on revenues of $235.2 million.
SINGAPORE: Embattled commodity trader Noble Group Ltd appointed an independent financial adviser to assess whether its controversial debt for equity rescue plan is fair, complying with a request from the Singapore regulator issued two months ago after the deal ran into opposition.
President Donald Trump’s decision to pull out of the Iran nuclear deal has pushed crude oil back above the $71-a-barrel threshold on fears the impact of economic sanctions (to say nothing of the threat of a military confrontation) on the output of Iranian crude into the marketplace.
The rise and development of new technology have encouraged the oil and gas industry to integrate new devices and systems into the market in an attempt to enhance efficiency, production levels and reduce overall costs.
The company's disappointing performance was largely driven by low fleet utilization, as several of its rigs were either idle or came off contract during the quarter.
7h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
8h - Asif
BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...